作者：
SmithII,J.W. [1]
;
Vukelja,S. [2]
;
Rabe,A. [3]
;
Wentworth-Hartung,N. [4]
;
Koutrelakos,N. [5]
;
Shao,S.H. [6]
;
Whittaker,T. [7]
;
Wang,Y. [8]
;
Asmar,L. [9]
;
McDowell,D.O. ;
Mukhopadhyay,P. ;
O'Shaughnessy,J.
作者单位：
Bristol-Myers Squibb, Princeton, NJ, United States
[1]
Maryland Oncology Hematology, Columbia, MD, United States
[2]
McKesson Speciality Health, The Woodlands, TX, United States
[3]
Compass Oncology, 5050 NE Hoyt Street, Portland, OR 97213, United States
[4]
Metro-Minnesota Community Clinical Oncology Program, St. Louis Park, MN, United States
[5]
Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX, United States
[6]
East Texas Medical Center, Clarksville, TX, United States
[7]
Kansas City Cancer Center, Shawnee Mission Medical Center, Overland Park, KS, United States
[8]
Central Indiana Cancer Centers, Anderson, IN, United States
[9]
发布时间
2018-08-24
换一批
